These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31151944)

  • 1. Anticoagulant Medications for the Prevention and Treatment of Thromboembolism.
    Brien L
    AACN Adv Crit Care; 2019; 30(2):126-138. PubMed ID: 31151944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New anticoagulants for treatment of venous thromboembolism.
    Franchini M; Mannucci PM
    Eur J Intern Med; 2012 Dec; 23(8):692-5. PubMed ID: 23095463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the Treatment of Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2016 Nov; 42(8):891-898. PubMed ID: 27764881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of New Oral Anticoagulants in the Treatment of Venous Thromboembolism and Thrombotic Prophylaxis.
    Akin M; Schäfer A; Akin I; Widder J; Brehm M
    Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):92-6. PubMed ID: 26666324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modern treatment of deep vein thrombosis and pulmonary embolism].
    Renczes J; Lindhoff-Last E
    Internist (Berl); 2019 Jun; 60(6):644-655. PubMed ID: 31119310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era.
    Toth PP
    Vasc Health Risk Manag; 2016; 12():23-34. PubMed ID: 26929637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and long-term management of venous thromboembolism.
    Al-Badri A; Spyropoulos AC
    Clin Lab Med; 2014 Sep; 34(3):519-36. PubMed ID: 25168940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism.
    Akwaa F; Spyropoulos AC
    Curr Med Res Opin; 2014 Nov; 30(11):2179-90. PubMed ID: 25105309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on diagnosis and anticoagulant therapy for venous thromboembolism.
    Stevens H; Tran H
    Intern Med J; 2018 Oct; 48(10):1175-1184. PubMed ID: 30288893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial management of venous thromboembolism].
    Mismetti P; Bertoletti L
    Rev Prat; 2015 Feb; 65(2):193-8. PubMed ID: 25939220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development in anticoagulant therapy.
    van Doormaal FF; Büller HR; Middeldorp S
    Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of anticoagulation therapy for venous thromboembolism.
    Bounameaux H; Perrier A
    Hematology Am Soc Hematol Educ Program; 2008; ():252-8. PubMed ID: 19074092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anticoagulants for the treatment of venous thromboembolism.
    Fernandes CJ; Alves Júnior JL; Gavilanes F; Prada LF; Morinaga LK; Souza R
    J Bras Pneumol; 2016 Apr; 42(2):146-54. PubMed ID: 27167437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Direct Oral Anticoagulants in the Management of Anticoagulation.
    Thakkar RN; Rathbun SW; Wright SM
    South Med J; 2017 Apr; 110(4):293-299. PubMed ID: 28376529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
    Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF
    J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.